One study, for example, showed that when people with obesity took injectable semaglutide, a GLP-1 receptor agonist, once weekly, they lost an average of 14.9 percent of their body weight over 68 weeks ...
Evidence shows that it’s adherence to a diet, rather than the diet itself, that influences how successful we are in losing weight and keeping it off. “My clients are far more motivated to stick with a ...